Pharmacokinetics of Acebutolol in the Elderly

  • W. Möhrke
  • E. Mutschler
  • W. Mühlberg
  • D. Platt
Conference paper


β- Blockers are used as first-line drugs in the treatment of hypertension. Acebutolol has also been shown to be effective and safe in an elderly population (Guerin et al. 1981). After absorption acebutolol is metabolized by hydrolysis of the amide group to the amine (metabolite I) and conjugated to diacetolol (metabolite II). A second minor metabolic pathway involves the reduction of the acetyl moiety (metabolite III) (Fig. 1).


Renal Clearance Single Oral Dose Young Volunteer Derly Patient Blank Serum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Guerin A, Baker PG, Goulton J (1981) Multi-centre study of acebutolol in hypertensive subjects: results for patients from the 50 to 64–years’ old and over 65 years’ old age groups. Curr Med Res Opinion 7: 179–184CrossRefGoogle Scholar
  2. Gulaid AA, James IM, Kaye CM, Lewellen ORW, Roberts E, Sankey M, Smith J, Templeton R, Thomas RJ (1981) The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HC1 as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.). Biopharmac Drug Disp 2: 103–114CrossRefGoogle Scholar
  3. Kirch W, Kohler H, Berggren G, Braun W (1982) The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite. Clin Nephrol 18: 88 - 94PubMedGoogle Scholar
  4. Meffin PJ, Harapat SR, Yee Y-G, Harrison DC (1977) High pressure liquid chromatographic analysis of drugs in biological fluids. V. Analysis of acebutolol and its major metabolite. J Chromatogr 138: 183–191Google Scholar
  5. Roux A, Flouvat B (1978) Méthode sensible de dosage de Pacebutolol et de son métabolite N- acetyle dans les milieux biologiques par chromatographic liquide haute performance avec detection de fluorescence. J Chromatogr 166: 327–332PubMedCrossRefGoogle Scholar
  6. Roux A, Henry JF, Fouache Y, Chan NP, Hervy MP, Forette F, Boudaris JP, Flouvat B (1983) A pharmacokinetic study of acebutolol in aged subjects as compared to young subjects. Gerontology 29: 202–208PubMedCrossRefGoogle Scholar
  7. Steyn JM (1976) A thin-layer chromatographic method for the determination of acebutolol and its major metabolite in serum. J Chromatogr 120: 465–472PubMedCrossRefGoogle Scholar
  8. Wagner JW (1975) Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, HamiltonGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • W. Möhrke
    • 1
  • E. Mutschler
    • 2
  • W. Mühlberg
    • 4
  • D. Platt
    • 3
    • 4
  1. 1.Röhm PharmaWeiterstadtGermany
  2. 2.Pharmakologisches Institut für NaturwissenschaftlerJ.W. Goethe-UniversitätFrankfurtGermany
  3. 3.Institut für GerontologieUniversität Erlangen-NürnbergGermany
  4. 4.2. Medizinische KlinikKlinikum NürnbergNürnbergGermany

Personalised recommendations